Arjo AB (publ)

Arjo AB (publ)

ARJO-B.ST
Arjo AB (publ)SE flagStockholm Stock Exchange
26.98
SEK
-0.24
- -
7.35BMarket Cap
Arjo AB (publ)
ARJO-B.ST
(Stockholm Stock Exchange)

Recent

price

26.98

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
29.78
31.93
28.67
28.23
30.17
32.96
33.33
33.3
36.64
40.31
41.46
40.39
41.36
Revenue per Share
- -
2.44
1.21
1.8
0.43
1.09
1.48
1.93
2.72
1.65
1.76
1.83
1.23
1.58
Basic EPS, GAAP
- -
3.77
3.19
2.18
-0.3
1.28
1.81
5.36
3.58
0.06
5.07
3.08
2.67
4.79
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.5
0.55
0.65
0.85
1.15
0.85
0.9
0.95
0.95
Dividend per Share
- -
37.89
36.26
36.75
17.09
17.93
18.35
20.04
21.84
22.25
23.01
23.98
24.32
23.75
Book Value per Share
- -
16.79
15.28
14.67
-5.73
-5.58
-4.25
-4.42
-1.41
0.15
0.88
2.52
0.89
0.72
Tangible Book Value per Share
- -
254
254
272
272
272
272
272
272
272
272
272
272
272
Basic Weighted Avg Shares
- -
7,568
8,115
7,808
7,688
8,217
8,976
9,078
9,070
9,979
10,980
11,292
11,000
11,264
Sales/Revenue/Turnover
- -
13.7
9
12.08
7.87
7.41
8.07
10.39
12.39
7.97
8.96
9.09
7.55
8.5
Operating Margin (%)
- -
635
681
755
715
687
1,004
973
956
985
1,058
1,078
1,092
1,111
Depreciation Expense
- -
619
307
490
118
296
403
526
742
449
480
498
334
430
Net Income, GAAP
- -
28.11
27.76
26.97
34.08
25.06
25.65
24.93
24.97
25.21
25
27.34
28.27
28.02
Effective Tax Rate (%)
- -
8.18
3.78
6.28
1.53
3.6
4.49
5.79
8.18
4.5
4.37
4.41
3.04
3.82
Profit Margin (%)
2,834
3,130
2,676
4,161
2,351
32
-1,126
-1,084
-2,459
238
21
254
564
972
Working Capital
348
357
475
1,361
5,131
2,900
885
802
948
3,632
3,187
3,014
3,495
780
LT Debt
9,296
10,602
10,227
10,658
5,074
5,427
5,914
5,630
6,714
7,432
7,582
8,338
7,457
7,536
Total Equity
- -
6.9
4.68
5.9
3.54
4.29
5.94
10.3
8.96
4.59
5.49
5.55
4.48
7.69
Return on Invested Capital (%)
- -
6.71
3.81
5.28
1.8
3.7
6.02
9.92
8.99
4.5
5.61
5.74
4.05
5.66
Return on Capital (%)
- -
6.56
3.26
5.1
1.61
6.21
8.16
10.06
13.01
7.48
7.79
7.78
5.08
6.75
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
2,404
407
406
LT Borrowings
2,163
- -
- -
LT Finance Leases
851
797
780
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
272
272
272
Market Capitalization
9,876
10,089
9,222

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
4,851
4,383
4,596
Cash, Cash Equivalents & STI
892
609
766
Accounts Receivable, Net
1,798
1,756
1,743
Inventories
1,388
1,341
1,380
Total Current Liabilities
4,597
4,439
3,624
Payables & Accruals
- -
- -
- -
ST Debt
2,404
407
406
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.57%
6.27%
-10.57%
Free Cash Flow
791.91%
1,670.65%
-13.25%
Net Income, GAAP
18.05%
-4.14%
-32.93%
Sales/Revenue/Turnover
3.21%
4.04%
-2.59%
Total Cash Common Dividend
- -
10.28%
5.71%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,759
2,810
2,734
2,989
11,292
2025
2,863
2,678
2,814
- -
11,000
2026
2,698
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.48
0.44
0.27
0.64
1.83
2025
0.33
0.34
0.26
- -
1.23
2026
0.4
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.9
- -
- -
0.9
2025
- -
0.95
- -
- -
0.95
2026
- -
- -
- -
- -
- -
Business
Arjo AB (publ) is a global medical technology company specializing in medical devices and solutions that enhance the quality of care for people affected by reduced mobility and age-related health challenges. The company offers a comprehensive range of products including patient handling and transfer equipment such as ergonomic patient lifts and standing aids; medical beds and support surfaces designed for pressure injury prevention; hygiene and disinfection systems to facilitate efficient care and infection control; vascular therapy devices focused on deep vein thrombosis prevention; and diagnostic systems including fetal and vascular monitoring. Arjo's solutions serve acute care, post-acute care, long-term care, and rehabilitation sectors primarily addressing needs in hospitals, nursing homes, and retirement facilities. Founded in 1957 by Arne Johansson, the company is headquartered in Malmö, Sweden, and operates in more than 100 countries with significant production sites in the Dominican Republic, Canada, China, Poland, and the United Kingdom. Recent major changes include strategic expansions through acquisitions in Europe, notably the acquisitions in 2024 of the French diagnostics distributor Tech Med and the German rental company GerroMed, which specializes in pressure injury prevention. These acquisitions strengthen Arjo's market positions in diagnostics and rental solutions in Germany and France, aiming for positive synergies from 2025 onwards. Additionally, in early 2025, Arjo launched the new bathing system Symbliss globally, further broadening its hygiene and infection control offerings. Leadership changes occurred with Niclas Sjöswärd appointed interim President & CEO following the departure of Joacim Lindoff, with Christofer Carlsson named interim CFO. Arjo continues to focus on growth and profitability improvements, particularly in key markets such as the US and UK, underpinning its commitment to innovation in healthcare mobility and patient care solutions. The company maintains a workforce of approximately 6,500 employees worldwide and reported net sales of about SEK 11 billion in 2023, positioning itself as a leading partner in healthcare environments by empowering movement and enhancing patient outcomes.